Russell Leek

15.2k citations

109 papers · 12.5k indexed · 5 hit papers · h-index 56

Impact in

Cancer Research top 0.1%
- Cancer, Hypoxia, and Metabolism
Oncology top 0.2%
- Cancer Cells and Metastasis
- Cancer Immunotherapy and Biomarkers
- Lymphatic System and Diseases

Papers in

Cancer Research 47
- Cancer, Hypoxia, and Metabolism 33
- Breast Cancer Treatment Studies 8
Oncology 41
- HER2/EGFR in Cancer Research 9
- Cancer Cells and Metastasis 7

Co-authors: Adrian L. Harris Claire E. Lewis Kevin C. Gatter Stephen B. Fox R Whitehouse Michael J. Greenall Helen Turley R J Landers
Journals: British Journal of Cancer (15 papers)Clinical Cancer Research (8 papers)The Journal of Pathology (8 papers)Cancer Research (5 papers)Breast Cancer Research and Treatment (5 papers)
Partner nations: United Kingdom United States India

In The Last Decade

Russell Leek

109 papers receiving 12.3k citations

Hit Papers

5 papers align trajectories log scale

Quantification of Regulatory T Cells Enables the Identification of High-Risk Breast Cancer Patients and Those at Risk of Late Relapse 2006 · 921 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2006 Journal of Clinical Oncology
2001 Journal of Clinical Oncology
1997 PubMed
1996 PubMed
1992 The Lancet

Peers

Countries citing papers authored by Russell Leek

Since Specialization

Citations

This map shows the geographic impact of Russell Leek's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Russell Leek with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Russell Leek more than expected).

Fields of papers citing papers by Russell Leek

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Russell Leek. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Russell Leek. The network helps show where Russell Leek may publish in the future.

Co-authors

The 25 scholars most cited alongside Russell Leek, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Russell Leek Line = papers co-authored together Russell Leek links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Low cytoplasmic NUB1 protein exerts hypoxic cell death with poorer prognosis in oestrogen receptor negative breast cancer patients Translational Oncology ·Ka‐Liong Tan, Syed Haider, Christos E. Zois, Jianting Hu, Helen Turley, Russell Leek, Francesca M. Buffa, Oreste Acuto, Adrian L. Harris, Francesco Pezzella	2024	1
2	ADGRL4/ELTD1 Expression in Breast Cancer Cells Induces Vascular Normalization and Immune Suppression Molecular Cancer Research ·Helen Sheldon, Esther Bridges, Ildefonso Silva, Massimo Masiero, David M. Favara, Dian Wang, Russell Leek, Cameron Snell, Ioannis Roxanis, Mira Kreuzer, Uzi Gileadi, Francesca M. Buffa, Alison H. Banham, Adrian L. Harris	2021	7
3	A Phase I First-in-Human Study of Enoticumab (REGN421), a Fully Human Delta-like Ligand 4 (Dll4) Monoclonal Antibody in Patients with Advanced Solid Tumors Clinical Cancer Research ·E. Gabriela Chiorean, Patricia LoRusso, Robert Matthew Strother, Jennifer R. Diamond, Anne Younger, Wells A. Messersmith, Lieve Adriaens, Li Liu, Richard Kao, A. Thomas DiCioccio, Ana Kostić, Russell Leek, Adrian L. Harris, Antonio Jimeno	2015	114
4	ADAM10 mediates trastuzumab resistance and is correlated with survival in HER2 positive breast cancer Oncotarget ·Katharina Feldinger, Daniele Generali, Gabriela Krämer-Marek, Merel Gijsen, Tzi Bun Ng, Jack Ho Wong, Carla Strina, Mariarosa Cappelletti, Daniele Andreis, Ji-Liang Li, Esther Bridges, Helen Turley, Russell Leek, Ioannis Roxanis, Jacek Capala, Gillian Murphy, Adrian L. Harris, Anthony Kong	2014	68
5	The G-Protein–Coupled Receptor CLR Is Upregulated in an Autocrine Loop with Adrenomedullin in Clear Cell Renal Cell Carcinoma and Associated with Poor Prognosis Clinical Cancer Research ·Leonid L. Nikitenko, Russell Leek, Stephen Henderson, Nischalan Pillay, Helen Turley, Daniele Generali, Sarah Gunningham, Helen Morrin, Andrea Pellagatti, Margaret Rees, Adrian L. Harris, Stephen B. Fox	2013	16
6	Carbonic Anhydrase IX Promotes Tumor Growth and Necrosis In Vivo and Inhibition Enhances Anti-VEGF Therapy Clinical Cancer Research ·Alan McIntyre, Shalini Patiar, Simon Wigfield, Jiliang Li, Ioanna Ledaki, Helen Turley, Russell Leek, Cameron Snell, Kevin C. Gatter, William S. Sly, Richard D. Vaughan‐Jones, Pawel Swietach, Adrian L. Harris	2012	188
7	CD31 angiogenesis and combined expression of HIF-1α and HIF-2α are prognostic in primary clear-cell renal cell carcinoma (CC-RCC), but HIFα transcriptional products are not: implications for antiangiogenic trials and HIFα biomarker studies in primary CC-RCC Carcinogenesis ·Swethajit Biswas, Philip J.S. Charlesworth, Gareth D. H. Turner, Russell Leek, Paul T. Thamboo, Leticia Campo, Helen Turley, Petra Dildey, Andrew Protheroe, David Cranston, Kevin C. Gatter, Francesco Pezzella, Adrian L. Harris	2012	46
8	DLL4-Notch Signaling Mediates Tumor Resistance to Anti-VEGF Therapy In Vivo Cancer Research ·Jiliang Li, Richard C.A. Sainson, Chern Ein Oon, Helen Turley, Russell Leek, Helen Sheldon, Esther Bridges, Wen Shi, Cameron Snell, Emma T. Bowden, Herren Wu, Partha S. Chowdhury, Angela J. Russell, Craig P. Montgomery, Richard Poulsom, Adrian L. Harris	2011	187
9	The Histone Demethylase JMJD2B Is Regulated by Estrogen Receptor α and Hypoxia, and Is a Key Mediator of Estrogen Induced Growth Cancer Research ·Jun Yang, Adrian M. Jubb, Luke Pike, Francesca M. Buffa, Helen Turley, Dilair Baban, Russell Leek, Kevin C. Gatter, Jiannis Ragoussis, Adrian L. Harris	2010	143
10	Delta-like 4 Notch Ligand Regulates Tumor Angiogenesis, Improves Tumor Vascular Function, and Promotes Tumor Growth In vivo Cancer Research ·Jiliang Li, Richard C.A. Sainson, Wen Shi, Russell Leek, Laura Harrington, Matthias Preusser, Swethajit Biswas, Helen Turley, Emily Heikamp, Johannes A. Hainfellner, Adrian L. Harris	2007	242
11	Expression of Terminally Glycosylated Calcitonin Receptor–Like Receptor in Uterine Leiomyoma: Endothelial Phenotype and Association with Microvascular Density Clinical Cancer Research ·Leonid L. Nikitenko, Tanya Cross, Leticia Campo, Helen Turley, Russell Leek, Sanjiv Manek, Roy Bicknell, Margaret Rees	2006	9
12	Molecular classification of breast carcinomas by immunohistochemistry (IHC) using the tissue microarrays (TMA): new subtypes with clinical relevance? Breast Cancer Research and Treatment ·Christine Desmedt, Denis Larsimont, Marianne Paesmans, Jean-Yves Leroy, Simon A. Fox, Russell Leek, Virginie Durbecq, M Kholik, C Ferrara, Ghizlane Rouas, Adrian L. Harris, Martine Piccart, Fátima Cardoso, Christos Sotiriou	2004	1
13	Cytoplasmic p21 WAF1/CIP1 expression is correlated with HER-2/ neu in breast cancer and is an independent predictor of prognosis Breast Cancer Research ·Zoë Winters, Russell Leek, Mike Bradburn, Chris J. Norbury, Adrian L. Harris	2003	86
14	Pharmacokinetic measurements of a 5FU pro-drug, capecitabine, in bladder tumours over-expressing thymidine phosphorylase Clinical Cancer Research ·Yuen‐Li Chung, Helen Troy, Ian Judson, Russell Leek, Martin O. Leach, Matthew C. Stubbs, Adrian L. Harris, Griffiths	2003	2
15	Relation of hypoxia-inducible factor-2 alpha (HIF-2 alpha) expression in tumor-infiltrative macrophages to tumor angiogenesis and the oxidative thymidine phosphorylase pathway in Human breast cancer. PubMed ·Russell Leek, Kate Talks, Francesco Pezzella, Helen Turley, Leticia Campo, Nicholas Brown, Roy Bicknell, Marian Taylor, Kevin C. Gatter, Adrian L. Harris	2002	177
16	Hypoxia-inducible factors HIF-1alpha and HIF-2alpha in head and neck cancer: relationship to tumor biology and treatment outcome in surgically resected patients. PubMed ·Nigel Beasley, Russell Leek, Mohammed H Alam, Helen Turley, Graham J. Cox, Kevin C. Gatter, Peter S. Millard, Sue Fuggle, Adrian L. Harris	2002	252
17	Microarray analysis of differential gene expression in HER2/neu -positive and -negative breast cancer cells Modern Pathology ·Knud Wilson, Russell Leek, Adrian L. Harris, Joseph Geradts	2001	1
18	Association of tumour necrosis factor alpha and its receptors with thymidine phosphorylase expression in invasive breast carcinoma British Journal of Cancer ·Russell Leek, R J Landers, Stephen B. Fox, F Ng, Adrian L. Harris, CE Lewis	1998	176
19	Bcl-2 and p53 expression in node-negative breast carcinoma: A study with long-term follow-up Human Pathology ·Mattia Barbareschi, Orazio Caffo, Silvio Veronese, Russell Leek, Paolo Fina, Stephen B. Fox, Mariella Bonzanini, Salvatore Girlando, Luca Morelli, Claudio Eccher, Francesco Pezzella, Claudio Doglioni, Paolo Palma, Adrian L. Harris	1996	92
20	Amphiregulin, epidermal growth factor receptor, and estrogen receptor expression in human primary breast cancer. PubMed ·S LeJeune, Russell Leek, E Horak, Gregory D. Plowman, Michael J. Greenall, Adrian L. Harris	1993	80

About Russell Leek

Russell Leek is a scholar working on Cancer Research, Oncology, Immunology and Allergy, Molecular Biology and Immunology, having authored 109 papers that have together received 12.5k indexed citations. Recurring topics across this work include Angiogenesis and VEGF in Cancer (38 papers), Cancer, Hypoxia, and Metabolism (33 papers), HER2/EGFR in Cancer Research (9 papers), Cell Adhesion Molecules Research (8 papers), Monoclonal and Polyclonal Antibodies Research (8 papers), Breast Cancer Treatment Studies (8 papers), Cancer Cells and Metastasis (7 papers) and Immune cells in cancer (7 papers). The work is most often cited by research in Cancer Research (4.5k citations), Oncology (5.1k citations), Immunology (2.6k citations), Molecular Biology (7.3k citations) and Immunology and Allergy (583 citations). Russell Leek has collaborated with scholars based in United Kingdom, United States and India. Frequent co-authors include Adrian L. Harris, Claire E. Lewis, Kevin C. Gatter, Stephen B. Fox, R Whitehouse, Michael J. Greenall, Helen Turley, R J Landers, Jane B. Clarke and S LeJeune. Their work appears in journals such as British Journal of Cancer, Clinical Cancer Research, The Journal of Pathology, Cancer Research and Breast Cancer Research and Treatment.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact